Ym 1994, daeth Sefydliad Ymchwil Jintan Depei i fodolaeth. Ar ôl mwy nag 20 mlynedd o frwydro ac arloesi, newidiodd y cwmni ei enw yn swyddogol i Jiangsu Jingye Pharmaceutical Co., Ltd. ar Fai 16, 2016, a chafodd y drwydded gweithgynhyrchu cyffuriau ar gyfer loratadine, crotamiton, hydrochlorid amitriptyline a chyffuriau eraill.
With decades of consistent persistence and efforts, Jingye Pharmaceutical's products have won high praise from customers at home and abroad. Mae cynhyrchion y cwmni wedi cael eu hallforio i Ewrop ac America ac wedi cael cofrestriad DMF a thystysgrif Dun & Bradstreet.
With decades of consistent persistence and efforts, Jingye Pharmaceutical's products have won high praise from customers at home and abroad. Mae cynhyrchion y cwmni wedi cael eu hallforio i Ewrop ac America ac wedi cael cofrestriad DMF a thystysgrif Dun & Bradstreet.